Furthermore, an anti-GITR treatment in mouse tumor models alters the number of tumor infiltrating Treg cells [40], and GITRL transgenic mice show an increased absolute number of T regulatory cells [41]. The gene discussed is TNFRSF18; the disease is neoplasm.